UNIVERSAL-WELLNESS-LABS
Digital Health Certificates are happening. Governments, airlines and the industry at large need solutions to get the people moving freely and safely. Universal Wellness Labs creates a wearable for hand cleaning that holds the QR-code for Health Certificates. The user-friendly gadget serves as an alternative medium, and as a back-up for the QR-codes in smartphone apps or printed on paper.
Health Certificates, a.k.a. Immunity Passports, Vaccine Certificates, Green Passes and PCR tests come as QR-code for storage in apps in people’s smartphones or printed on paper.
Universal Wellness Labs foresees potential issues and uses NFC as a medium for the QR.
It pairs the Health Certificate with hand hygiene in one useful and user-friendly wearable dispenser for hand sanitizer: the Zpritzi.
Marinus Vander Slikke, CEO of Universal Wellness Labs: “A document as vital as a Health Certificate must have a back-up. Apps can crash. Smartphones can die. Paper-printed QR-codes are old world, prone to forgery and get lost easily.”
NFC is secure, contactless and works without electronics and networks.
A video-presentation of the Zpritzi concept is available at www.zpritzi.com .
Universal Wellness Labs recently presented its concept to the European Commission.
Marinus Vander Slikke: “We anticipate deeper negotiations soon. Sweden and Denmark have already endorsed NFC. However, we are also targeting the private sector like airlines, hotels, cruise ships and event organisers.”
Zpritzi is a slim, elongated and ergonomic designed wearable gadget. Made from recyclable ABS. Refillable with any sanitizer spray. An integrated encrypted NFC tag stores the QR-code. People wear it around their neck, or on their belt or hand-bag.
Zpritzi is low-cost and an ideal product for corporate branding: It verifies people’s health status, makes hand disinfection easy and is a promotional tool with lasting marketing effects.
A pilot study with 88 participants shows the efficacy of the Zpritzi. Users clean their hands 75% more often with a Zpritzi than with conventional portable bottles.
Marinus Vander Slikke: “Hand cleaning is a first line of defence against any kind of bacteria and viruses, including Covid. Both the public and the private sector require proof of health to enter their country or premises. A quick scan of the Zpritzi verifies people’s health status. And the big advantage is that people always go in with clean hands.”
“In the new normal people still want to be trendy and look smart. Similar to face masks, Zpritzi makes the Health Certificate and hand sanitizing cool.”
Zpritzi is created in cooperation with Design2Gather, an award winning Dutch design company (design2gather.com ).
Universal Wellness Labs OÜ is an Estonia based company that conceptualizes and designs products for personal health and wellness (universalwellnesslabs.com ).
###
View source version on businesswire.com: https://www.businesswire.com/news/home/20210505005604/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lilac and Traxys Announce Binding 10-Year Offtake Agreement for Great Salt Lake Lithium Production12.1.2026 13:00:00 CET | Press release
Definitive agreement secures 100% of Phase 1 production, advancing project toward final investment decision Lilac Solutions, a leading provider of direct lithium extraction technology, and Traxys North America, a leading global physical trader and merchant in metals and natural resources, today announced a binding 10-year offtake agreement for lithium carbonate produced at Lilac's Great Salt Lake facility in Utah. The agreement represents a major milestone in advancing the project toward construction and establishes a clear commercial pathway for one of the nearest-term domestic lithium projects in the United States. Under the terms of the definitive agreement, Traxys will purchase 50,000 tonnes of lithium carbonate over a 10-year period, representing 100% of the planned Phase 1 production capacity. The agreement is take-or-pay, with agreed pricing mechanisms linked to market indices. The Great Salt Lake Phase 1 facility is designed to produce 5,000 tonnes per annum of battery-grade li
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom